Novel motif:65: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:51, 9 September 2013
name: | motif65_TNGCGA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006396 | RNA processing | 1.970124e-11 |
GO:0034660 | ncRNA metabolic process | 2.146778e-11 |
GO:0034470 | ncRNA processing | 3.375181e-11 |
GO:0045116 | protein neddylation | 1.034544e-10 |
GO:0022613 | ribonucleoprotein complex biogenesis | 5.535259e-9 |
GO:0016180 | snRNA processing | 8.047392e-9 |
GO:0043543 | protein acylation | 9.629253e-9 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.300118e-8 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 2.510779e-8 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.287738e-8 |
GO:0016570 | histone modification | 4.580263e-8 |
GO:0016569 | covalent chromatin modification | 5.059332e-8 |
GO:0006473 | protein acetylation | 5.648951e-8 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 8.888637e-8 |
GO:0030433 | ER-associated protein catabolic process | 9.934045e-8 |
GO:0016073 | snRNA metabolic process | 1.165964e-7 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.398735e-7 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 1.506243e-7 |
GO:0006353 | transcription termination, DNA-dependent | 1.713673e-7 |
GO:0006475 | internal protein amino acid acetylation | 1.936192e-7 |
GO:0006281 | DNA repair | 2.073519e-7 |
GO:0006415 | translational termination | 2.266165e-7 |
GO:0006370 | mRNA capping | 2.752967e-7 |
GO:0015817 | histidine transport | 3.564809e-7 |
GO:0071843 | cellular component biogenesis at cellular level | 3.806995e-7 |
GO:0010225 | response to UV-C | 5.948423e-7 |
GO:0030970 | retrograde protein transport, ER to cytosol | 6.422007e-7 |
GO:0016573 | histone acetylation | 6.484867e-7 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 7.179458e-7 |
GO:0060023 | soft palate development | 8.613986e-7 |
GO:0016070 | RNA metabolic process | 9.170926e-7 |
GO:0032259 | methylation | 1.032176e-6 |
GO:0006369 | termination of RNA polymerase II transcription | 1.224486e-6 |
GO:0090304 | nucleic acid metabolic process | 1.346556e-6 |
GO:0042538 | hyperosmotic salinity response | 1.490497e-6 |
GO:0018394 | peptidyl-lysine acetylation | 1.532568e-6 |
GO:0009452 | RNA capping | 1.653008e-6 |
GO:0090083 | regulation of inclusion body assembly | 1.838462e-6 |
GO:0018393 | internal peptidyl-lysine acetylation | 2.176165e-6 |
GO:0006189 | 'de novo' IMP biosynthetic process | 2.326595e-6 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 2.529457e-6 |
GO:0015742 | alpha-ketoglutarate transport | 2.529457e-6 |
GO:0043503 | skeletal muscle fiber adaptation | 2.544205e-6 |
GO:0006481 | C-terminal protein methylation | 2.546979e-6 |
GO:0043624 | cellular protein complex disassembly | 2.861650e-6 |
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 3.006836e-6 |
GO:0019083 | viral transcription | 3.302082e-6 |
GO:0006354 | transcription elongation, DNA-dependent | 3.487939e-6 |
GO:0051095 | regulation of helicase activity | 3.984984e-6 |
GO:0008033 | tRNA processing | 4.127689e-6 |
GO:0046755 | non-lytic virus budding | 4.150157e-6 |
GO:0042073 | intraflagellar transport | 4.150157e-6 |
GO:0016071 | mRNA metabolic process | 4.371010e-6 |
GO:0034623 | cellular macromolecular complex disassembly | 5.629841e-6 |
GO:0006172 | ADP biosynthetic process | 5.645781e-6 |
GO:0033205 | cell cycle cytokinesis | 5.802148e-6 |
GO:0042254 | ribosome biogenesis | 6.612168e-6 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 6.723741e-6 |
GO:0006289 | nucleotide-excision repair | 6.816506e-6 |
GO:0061084 | negative regulation of protein refolding | 6.864985e-6 |
GO:0035621 | ER to Golgi ceramide transport | 6.968379e-6 |
GO:0042274 | ribosomal small subunit biogenesis | 8.274939e-6 |
GO:0042696 | menarche | 9.032583e-6 |
GO:0051292 | nuclear pore complex assembly | 9.207882e-6 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.114864e-5 |
GO:0071826 | ribonucleoprotein complex subunit organization | 1.123173e-5 |
GO:0016072 | rRNA metabolic process | 1.232935e-5 |
GO:0043241 | protein complex disassembly | 1.320310e-5 |
GO:0010467 | gene expression | 1.422359e-5 |
GO:0022618 | ribonucleoprotein complex assembly | 1.468032e-5 |
GO:0002679 | respiratory burst involved in defense response | 1.703128e-5 |
GO:0070625 | zymogen granule exocytosis | 1.712417e-5 |
GO:0035721 | intraflagellar retrograde transport | 1.778714e-5 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 2.025819e-5 |
GO:0032984 | macromolecular complex disassembly | 2.090538e-5 |
GO:0051028 | mRNA transport | 2.098009e-5 |
GO:0006545 | glycine biosynthetic process | 2.287704e-5 |
GO:0060996 | dendritic spine development | 2.574330e-5 |
GO:0006379 | mRNA cleavage | 2.583146e-5 |
GO:0006479 | protein methylation | 2.838367e-5 |
GO:0006406 | mRNA export from nucleus | 2.984688e-5 |
GO:0006325 | chromatin organization | 3.511889e-5 |
GO:0050434 | positive regulation of viral transcription | 3.576898e-5 |
GO:0051096 | positive regulation of helicase activity | 3.788343e-5 |
GO:0008380 | RNA splicing | 3.898158e-5 |
GO:0016568 | chromatin modification | 3.908303e-5 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 4.163128e-5 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.174219e-5 |
GO:0043622 | cortical microtubule organization | 4.258879e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 4.258879e-5 |
GO:0030103 | vasopressin secretion | 4.258879e-5 |
GO:0015986 | ATP synthesis coupled proton transport | 4.347799e-5 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 4.464357e-5 |
GO:0061032 | visceral serous pericardium development | 4.464357e-5 |
GO:0042759 | long-chain fatty acid biosynthetic process | 4.704180e-5 |
GO:0071394 | cellular response to testosterone stimulus | 4.716716e-5 |
GO:0006414 | translational elongation | 5.352083e-5 |
GO:0071545 | inositol phosphate catabolic process | 5.483473e-5 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 5.796175e-5 |
GO:0006730 | one-carbon metabolic process | 6.149307e-5 |
GO:0044265 | cellular macromolecule catabolic process | 6.296226e-5 |
GO:0002149 | hypochlorous acid biosynthetic process | 6.562678e-5 |
GO:0046105 | thymidine biosynthetic process | 6.671312e-5 |
GO:0060465 | pharynx development | 6.671312e-5 |
GO:0043414 | macromolecule methylation | 6.703318e-5 |
GO:0048813 | dendrite morphogenesis | 6.847374e-5 |
GO:0021759 | globus pallidus development | 7.405545e-5 |
GO:0051568 | histone H3-K4 methylation | 7.679452e-5 |
GO:0051289 | protein homotetramerization | 7.831454e-5 |
GO:0034645 | cellular macromolecule biosynthetic process | 7.840323e-5 |
GO:0019941 | modification-dependent protein catabolic process | 8.663674e-5 |
GO:0031081 | nuclear pore distribution | 8.724249e-5 |
GO:0006412 | translation | 9.501512e-5 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 9.679580e-5 |
GO:0006188 | IMP biosynthetic process | 9.764276e-5 |
GO:0002003 | angiotensin maturation | 1.006598e-4 |
GO:0043632 | modification-dependent macromolecule catabolic process | 1.014731e-4 |
GO:0019673 | GDP-mannose metabolic process | 1.040475e-4 |
GO:0000725 | recombinational repair | 1.049107e-4 |
GO:0021603 | cranial nerve formation | 1.053813e-4 |
GO:0001945 | lymph vessel development | 1.162236e-4 |
GO:0035722 | interleukin-12-mediated signaling pathway | 1.170301e-4 |
GO:0042026 | protein refolding | 1.250107e-4 |
GO:0072166 | posterior mesonephric tubule development | 1.301932e-4 |
GO:0018205 | peptidyl-lysine modification | 1.442229e-4 |
GO:0032793 | positive regulation of CREB transcription factor activity | 1.639550e-4 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 1.665744e-4 |
GO:0001676 | long-chain fatty acid metabolic process | 1.670607e-4 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.732336e-4 |
GO:0060997 | dendritic spine morphogenesis | 1.956369e-4 |
GO:0035470 | positive regulation of vascular wound healing | 2.078184e-4 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 2.195814e-4 |
GO:0006413 | translational initiation | 2.199664e-4 |
GO:0006772 | thiamine metabolic process | 2.454854e-4 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 2.481680e-4 |
GO:0007231 | osmosensory signaling pathway | 2.481680e-4 |
GO:0006173 | dADP biosynthetic process | 2.559307e-4 |
GO:0006901 | vesicle coating | 2.627443e-4 |
GO:0001732 | formation of translation initiation complex | 2.708394e-4 |
GO:0034968 | histone lysine methylation | 2.720924e-4 |
GO:0006364 | rRNA processing | 2.764943e-4 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 2.774771e-4 |
GO:0042450 | arginine biosynthetic process via ornithine | 2.774771e-4 |
GO:0051276 | chromosome organization | 2.779024e-4 |
GO:0030208 | dermatan sulfate biosynthetic process | 2.902396e-4 |
GO:0000022 | mitotic spindle elongation | 2.902396e-4 |
GO:0032774 | RNA biosynthetic process | 2.965367e-4 |
GO:0016571 | histone methylation | 3.106189e-4 |
GO:0046434 | organophosphate catabolic process | 3.130594e-4 |
GO:0070672 | response to interleukin-15 | 3.160625e-4 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 3.244747e-4 |
GO:0009304 | tRNA transcription | 3.264977e-4 |
GO:0009386 | translational attenuation | 3.280086e-4 |
GO:0000724 | double-strand break repair via homologous recombination | 3.328140e-4 |
GO:0006013 | mannose metabolic process | 3.367862e-4 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 3.800939e-4 |
GO:0046855 | inositol phosphate dephosphorylation | 3.857902e-4 |
GO:0042723 | thiamine-containing compound metabolic process | 3.911598e-4 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 3.985458e-4 |
GO:0072298 | regulation of metanephric glomerulus development | 3.991779e-4 |
GO:0032786 | positive regulation of transcription elongation, DNA-dependent | 3.991779e-4 |
GO:0022601 | menstrual cycle phase | 4.215164e-4 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 4.261838e-4 |
GO:0071557 | histone H3-K27 demethylation | 4.292198e-4 |
GO:0035574 | histone H4-K20 demethylation | 4.292198e-4 |
GO:0006310 | DNA recombination | 4.389581e-4 |
GO:0016575 | histone deacetylation | 4.407037e-4 |
GO:0043501 | skeletal muscle adaptation | 4.509983e-4 |
GO:0043966 | histone H3 acetylation | 4.593608e-4 |
GO:0009059 | macromolecule biosynthetic process | 4.615120e-4 |
GO:2000195 | negative regulation of female gonad development | 4.627951e-4 |
GO:0006397 | mRNA processing | 4.880457e-4 |
GO:0014813 | satellite cell commitment | 4.965693e-4 |
GO:0006051 | N-acetylmannosamine metabolic process | 4.965693e-4 |
GO:0080154 | regulation of fertilization | 5.142921e-4 |
GO:0035724 | CD24 biosynthetic process | 5.142921e-4 |
GO:2000438 | negative regulation of monocyte extravasation | 5.142921e-4 |
GO:0035723 | interleukin-15-mediated signaling pathway | 5.142921e-4 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 5.142921e-4 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 5.184687e-4 |
GO:0090084 | negative regulation of inclusion body assembly | 5.425770e-4 |
GO:2000194 | regulation of female gonad development | 5.436820e-4 |
GO:0042278 | purine nucleoside metabolic process | 5.477261e-4 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 5.941430e-4 |
GO:0006476 | protein deacetylation | 6.100544e-4 |
GO:0016926 | protein desumoylation | 6.148990e-4 |
GO:0048532 | anatomical structure arrangement | 6.336212e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 6.495078e-4 |
GO:0010626 | negative regulation of Schwann cell proliferation | 6.711008e-4 |
GO:0060839 | endothelial cell fate commitment | 6.711008e-4 |
GO:0044257 | cellular protein catabolic process | 7.045268e-4 |
GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 7.080819e-4 |
GO:0007422 | peripheral nervous system development | 7.109313e-4 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 7.169818e-4 |
GO:0003406 | retinal pigment epithelium development | 7.178850e-4 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 7.542794e-4 |
GO:0051569 | regulation of histone H3-K4 methylation | 7.607480e-4 |
GO:0003341 | cilium movement | 8.369492e-4 |
GO:0065001 | specification of axis polarity | 8.873834e-4 |
GO:0061157 | mRNA destabilization | 8.958412e-4 |
GO:0045090 | retroviral genome replication | 8.958412e-4 |
GO:0006450 | regulation of translational fidelity | 8.958412e-4 |
GO:0008295 | spermidine biosynthetic process | 8.958412e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 8.958412e-4 |
GO:0035601 | protein deacylation | 9.083200e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 9.145122e-4 |
GO:0006366 | transcription from RNA polymerase II promoter | 9.160452e-4 |
GO:0046323 | glucose import | 9.209699e-4 |
GO:0007141 | male meiosis I | 9.251359e-4 |
GO:0010498 | proteasomal protein catabolic process | 9.481117e-4 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 9.516440e-4 |
GO:0014034 | neural crest cell fate commitment | 9.910947e-4 |
GO:0006399 | tRNA metabolic process | 9.970495e-4 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 1.002087e-3 |
GO:0009057 | macromolecule catabolic process | 1.011587e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.032023e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 1.060286e-3 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.074770e-3 |
GO:0046782 | regulation of viral transcription | 1.129122e-3 |
GO:0032425 | positive regulation of mismatch repair | 1.137516e-3 |
GO:0016344 | meiotic chromosome movement towards spindle pole | 1.137516e-3 |
GO:0001842 | neural fold formation | 1.137516e-3 |
GO:0034498 | early endosome to Golgi transport | 1.149215e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 1.155868e-3 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 1.166511e-3 |
GO:0048205 | COPI coating of Golgi vesicle | 1.166511e-3 |
GO:0043647 | inositol phosphate metabolic process | 1.184458e-3 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 1.202568e-3 |
GO:0015993 | molecular hydrogen transport | 1.231425e-3 |
GO:0006513 | protein monoubiquitination | 1.244361e-3 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 1.251692e-3 |
GO:0007518 | myoblast cell fate determination | 1.263173e-3 |
GO:0006405 | RNA export from nucleus | 1.272197e-3 |
GO:0021871 | forebrain regionalization | 1.313946e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 1.355151e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 1.355151e-3 |
GO:0022616 | DNA strand elongation | 1.362726e-3 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 1.376029e-3 |
GO:0018916 | nitrobenzene metabolic process | 1.376029e-3 |
GO:0014037 | Schwann cell differentiation | 1.421717e-3 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.428130e-3 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 1.468033e-3 |
GO:0006900 | membrane budding | 1.499056e-3 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 1.517346e-3 |
GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 1.517346e-3 |
GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process | 1.517346e-3 |
GO:0007634 | optokinetic behavior | 1.517346e-3 |
GO:0021599 | abducens nerve formation | 1.517346e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 1.517346e-3 |
GO:0048208 | COPII vesicle coating | 1.636694e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 1.711476e-3 |
GO:0009956 | radial pattern formation | 1.715179e-3 |
GO:0032055 | negative regulation of translation in response to stress | 1.740327e-3 |
GO:0006401 | RNA catabolic process | 1.793950e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.818927e-3 |
GO:0042255 | ribosome assembly | 1.833404e-3 |
GO:0009226 | nucleotide-sugar biosynthetic process | 1.847219e-3 |
GO:0006684 | sphingomyelin metabolic process | 1.901335e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 1.944929e-3 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 2.043547e-3 |
GO:0070537 | histone H2A K63-linked deubiquitination | 2.043547e-3 |
GO:0002268 | follicular dendritic cell differentiation | 2.048673e-3 |
GO:0006903 | vesicle targeting | 2.098978e-3 |
GO:0022011 | myelination in peripheral nervous system | 2.103453e-3 |
GO:0031584 | activation of phospholipase D activity | 2.120297e-3 |
GO:0017148 | negative regulation of translation | 2.146544e-3 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 2.222615e-3 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 2.222615e-3 |
GO:0010587 | miRNA catabolic process | 2.278564e-3 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 2.278564e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 2.295225e-3 |
GO:0009303 | rRNA transcription | 2.362925e-3 |
GO:0034214 | protein hexamerization | 2.367404e-3 |
GO:0045830 | positive regulation of isotype switching | 2.386285e-3 |
GO:0035565 | regulation of pronephros size | 2.409349e-3 |
GO:0039020 | pronephric nephron tubule development | 2.409349e-3 |
GO:0072284 | metanephric S-shaped body morphogenesis | 2.426656e-3 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 2.501996e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 2.503115e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 2.503115e-3 |
GO:0002175 | protein localization to paranode region of axon | 2.503115e-3 |
GO:0051168 | nuclear export | 2.537050e-3 |
GO:0006895 | Golgi to endosome transport | 2.656011e-3 |
GO:0048194 | Golgi vesicle budding | 2.703634e-3 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 2.739515e-3 |
GO:0048266 | behavioral response to pain | 2.740787e-3 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.744910e-3 |
GO:0032922 | circadian regulation of gene expression | 2.761279e-3 |
GO:0018243 | protein O-linked glycosylation via threonine | 2.780909e-3 |
GO:0018242 | protein O-linked glycosylation via serine | 2.780909e-3 |
GO:0030163 | protein catabolic process | 2.787357e-3 |
GO:0061383 | trabecula morphogenesis | 2.818392e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 2.862236e-3 |
GO:0006986 | response to unfolded protein | 2.897468e-3 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 2.916530e-3 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 2.916530e-3 |
GO:0060466 | activation of meiosis involved in egg activation | 2.916530e-3 |
GO:0000018 | regulation of DNA recombination | 3.116810e-3 |
GO:0048343 | paraxial mesodermal cell fate commitment | 3.118690e-3 |
GO:0061384 | heart trabecular morphogenesis | 3.248882e-3 |
GO:0031123 | RNA 3'-end processing | 3.313556e-3 |
GO:0040038 | polar body extrusion after meiotic divisions | 3.331754e-3 |
GO:0021571 | rhombomere 5 development | 3.338484e-3 |
GO:0009648 | photoperiodism | 3.423048e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 3.488436e-3 |
GO:0021754 | facial nucleus development | 3.506382e-3 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 3.530651e-3 |
GO:0048665 | neuron fate specification | 3.551495e-3 |
GO:0031124 | mRNA 3'-end processing | 3.589465e-3 |
GO:0070544 | histone H3-K36 demethylation | 3.614669e-3 |
GO:0045911 | positive regulation of DNA recombination | 3.669305e-3 |
GO:0060836 | lymphatic endothelial cell differentiation | 3.829156e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 3.845120e-3 |
GO:0035022 | positive regulation of Rac protein signal transduction | 3.845120e-3 |
GO:0042780 | tRNA 3'-end processing | 3.874193e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 4.005577e-3 |
GO:0000722 | telomere maintenance via recombination | 4.038136e-3 |
GO:0032070 | regulation of deoxyribonuclease activity | 4.085443e-3 |
GO:0047484 | regulation of response to osmotic stress | 4.085443e-3 |
GO:0060271 | cilium morphogenesis | 4.090177e-3 |
GO:0051882 | mitochondrial depolarization | 4.175237e-3 |
GO:0006424 | glutamyl-tRNA aminoacylation | 4.175237e-3 |
GO:0006287 | base-excision repair, gap-filling | 4.383748e-3 |
GO:0006302 | double-strand break repair | 4.566086e-3 |
GO:0072044 | collecting duct development | 4.609452e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.666472e-3 |
GO:0006596 | polyamine biosynthetic process | 4.666514e-3 |
GO:0009153 | purine deoxyribonucleotide biosynthetic process | 4.700355e-3 |
GO:0001826 | inner cell mass cell differentiation | 4.700355e-3 |
GO:0021604 | cranial nerve structural organization | 4.751263e-3 |
GO:0032785 | negative regulation of transcription elongation, DNA-dependent | 4.768491e-3 |
GO:0060419 | heart growth | 4.844234e-3 |
GO:2000824 | negative regulation of androgen receptor activity | 4.867840e-3 |
GO:0071048 | nuclear retention of unspliced pre-mRNA at the site of transcription | 4.867840e-3 |
GO:0043308 | eosinophil degranulation | 4.867840e-3 |
GO:0033594 | response to hydroxyisoflavone | 4.867840e-3 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 4.908549e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 4.909813e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 4.917223e-3 |
GO:0014044 | Schwann cell development | 4.980247e-3 |
GO:0071108 | protein K48-linked deubiquitination | 5.029054e-3 |
GO:2000597 | positive regulation of optic nerve formation | 5.344391e-3 |
GO:0061360 | optic chiasma development | 5.344391e-3 |
GO:0021633 | optic nerve structural organization | 5.344391e-3 |
GO:0021650 | vestibulocochlear nerve formation | 5.344391e-3 |
GO:0035799 | ureter maturation | 5.344391e-3 |
GO:0048102 | autophagic cell death | 5.413171e-3 |
GO:0003017 | lymph circulation | 5.425076e-3 |
GO:0034661 | ncRNA catabolic process | 5.494731e-3 |
GO:0060038 | cardiac muscle cell proliferation | 5.518126e-3 |
GO:0019852 | L-ascorbic acid metabolic process | 5.547381e-3 |
GO:0006403 | RNA localization | 5.551187e-3 |
GO:0021612 | facial nerve structural organization | 5.613770e-3 |
GO:0044260 | cellular macromolecule metabolic process | 5.626184e-3 |
GO:0050684 | regulation of mRNA processing | 5.649560e-3 |
GO:0060017 | parathyroid gland development | 5.688978e-3 |
GO:0035083 | cilium axoneme assembly | 5.699557e-3 |
GO:0060459 | left lung development | 5.749723e-3 |
GO:0044258 | intestinal lipid catabolic process | 5.791286e-3 |
GO:0018350 | protein esterification | 5.791286e-3 |
GO:0021569 | rhombomere 3 development | 5.936861e-3 |
GO:0014029 | neural crest formation | 5.936861e-3 |
GO:0048524 | positive regulation of viral reproduction | 6.197924e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 6.245441e-3 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 6.251622e-3 |
GO:0045113 | regulation of integrin biosynthetic process | 6.253436e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 6.283843e-3 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 6.287555e-3 |
GO:0072148 | epithelial cell fate commitment | 6.324097e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 6.377557e-3 |
GO:0030539 | male genitalia development | 6.408387e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 6.484292e-3 |
GO:0006867 | asparagine transport | 6.514205e-3 |
GO:0070904 | transepithelial L-ascorbic acid transport | 6.532133e-3 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 6.532133e-3 |
GO:0045947 | negative regulation of translational initiation | 6.589487e-3 |
GO:0060708 | spongiotrophoblast differentiation | 6.663742e-3 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 6.749244e-3 |
GO:0015959 | diadenosine polyphosphate metabolic process | 6.858537e-3 |
GO:0007197 | inhibition of adenylate cyclase activity by muscarinic acetylcholine receptor signaling pathway | 6.874040e-3 |
GO:0018216 | peptidyl-arginine methylation | 6.884791e-3 |
GO:0060298 | positive regulation of sarcomere organization | 6.948883e-3 |
GO:0031055 | chromatin remodeling at centromere | 6.952511e-3 |
GO:0070370 | cellular heat acclimation | 7.075789e-3 |
GO:0071169 | establishment of protein localization to chromatin | 7.075789e-3 |
GO:0009436 | glyoxylate catabolic process | 7.075789e-3 |
GO:0000056 | ribosomal small subunit export from nucleus | 7.075789e-3 |
GO:0006351 | transcription, DNA-dependent | 7.328876e-3 |
GO:0035409 | histone H3-Y41 phosphorylation | 7.383139e-3 |
GO:0044088 | regulation of vacuole organization | 7.383139e-3 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 7.383139e-3 |
GO:0008216 | spermidine metabolic process | 7.383139e-3 |
GO:0010172 | embryonic body morphogenesis | 7.417795e-3 |
GO:0006499 | N-terminal protein myristoylation | 7.428982e-3 |
GO:0060039 | pericardium development | 7.459951e-3 |
GO:0060297 | regulation of sarcomere organization | 7.485681e-3 |
GO:0035020 | regulation of Rac protein signal transduction | 7.559439e-3 |
GO:0014888 | striated muscle adaptation | 7.590031e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 7.675371e-3 |
GO:0032203 | telomere formation via telomerase | 7.745028e-3 |
GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity | 7.876957e-3 |
GO:0006284 | base-excision repair | 7.882468e-3 |
GO:0060343 | trabecula formation | 7.922871e-3 |
GO:0050658 | RNA transport | 8.127330e-3 |
GO:0051461 | positive regulation of corticotropin secretion | 8.190291e-3 |
GO:0060398 | regulation of growth hormone receptor signaling pathway | 8.193650e-3 |
GO:0048793 | pronephros development | 8.328162e-3 |
GO:0021561 | facial nerve development | 8.541519e-3 |
GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process | 8.801205e-3 |
GO:0015884 | folic acid transport | 9.134293e-3 |
GO:0070171 | negative regulation of tooth mineralization | 9.158455e-3 |
GO:0046543 | development of secondary female sexual characteristics | 9.311163e-3 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 9.417622e-3 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 9.417622e-3 |
GO:0046602 | regulation of mitotic centrosome separation | 9.439792e-3 |
GO:0000921 | septin ring assembly | 9.506901e-3 |
GO:0006505 | GPI anchor metabolic process | 9.620987e-3 |
GO:0035732 | nitric oxide storage | 9.637241e-3 |
GO:0042407 | cristae formation | 9.637241e-3 |
GO:0035726 | common myeloid progenitor cell proliferation | 9.637241e-3 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 9.637241e-3 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.637241e-3 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 9.637241e-3 |
GO:0000073 | spindle pole body separation | 9.637241e-3 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.637241e-3 |
GO:0071845 | cellular component disassembly at cellular level | 9.662519e-3 |
GO:0042268 | regulation of cytolysis | 9.828321e-3 |
GO:0033261 | regulation of S phase | 9.925792e-3 |
GO:0090303 | positive regulation of wound healing | 1.000027e-2 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1.002268e-2 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 1.003151e-2 |
GO:0015879 | carnitine transport | 1.005771e-2 |
GO:0055017 | cardiac muscle tissue growth | 1.006492e-2 |
GO:0030488 | tRNA methylation | 1.012170e-2 |
GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 1.012170e-2 |
GO:0042094 | interleukin-2 biosynthetic process | 1.015334e-2 |
GO:0006536 | glutamate metabolic process | 1.030909e-2 |
GO:0010624 | regulation of Schwann cell proliferation | 1.033265e-2 |
GO:0043967 | histone H4 acetylation | 1.038481e-2 |
GO:0042167 | heme catabolic process | 1.039608e-2 |
GO:0021610 | facial nerve morphogenesis | 1.039608e-2 |
GO:0008625 | induction of apoptosis via death domain receptors | 1.067301e-2 |
GO:0032423 | regulation of mismatch repair | 1.071539e-2 |
GO:0035966 | response to topologically incorrect protein | 1.079024e-2 |
GO:0045299 | otolith mineralization | 1.089393e-2 |
GO:0007140 | male meiosis | 1.093309e-2 |
GO:0002002 | regulation of angiotensin levels in blood | 1.093954e-2 |
GO:0048935 | peripheral nervous system neuron development | 1.099934e-2 |
GO:0072179 | nephric duct formation | 1.106294e-2 |
GO:0072164 | mesonephric tubule development | 1.112367e-2 |
GO:0048024 | regulation of nuclear mRNA splicing, via spliceosome | 1.116647e-2 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 1.117289e-2 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.118092e-2 |
GO:0006342 | chromatin silencing | 1.135131e-2 |
GO:0046340 | diacylglycerol catabolic process | 1.163105e-2 |
GO:0046168 | glycerol-3-phosphate catabolic process | 1.163560e-2 |
GO:0033262 | regulation of DNA replication involved in S phase | 1.163560e-2 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 1.166288e-2 |
GO:0039003 | pronephric field specification | 1.166288e-2 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 1.166288e-2 |
GO:0043491 | protein kinase B signaling cascade | 1.180424e-2 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 1.207163e-2 |
GO:0071602 | phytosphingosine biosynthetic process | 1.207163e-2 |
GO:0048859 | formation of anatomical boundary | 1.214946e-2 |
GO:0033002 | muscle cell proliferation | 1.215999e-2 |
GO:0019388 | galactose catabolic process | 1.219290e-2 |
GO:0007007 | inner mitochondrial membrane organization | 1.220206e-2 |
GO:0070671 | response to interleukin-12 | 1.225801e-2 |
GO:0042135 | neurotransmitter catabolic process | 1.229806e-2 |
GO:0070286 | axonemal dynein complex assembly | 1.231935e-2 |
GO:0072205 | metanephric collecting duct development | 1.253281e-2 |
GO:0070723 | response to cholesterol | 1.280410e-2 |
GO:0002663 | positive regulation of B cell tolerance induction | 1.286403e-2 |
GO:0072215 | regulation of metanephros development | 1.288095e-2 |
GO:0018279 | protein N-linked glycosylation via asparagine | 1.328048e-2 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 1.330592e-2 |
GO:0007217 | tachykinin receptor signaling pathway | 1.334445e-2 |
GO:0072181 | mesonephric duct formation | 1.344051e-2 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 1.344051e-2 |
GO:0097152 | mesenchymal cell apoptosis | 1.344051e-2 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 1.344051e-2 |
GO:0060982 | coronary artery morphogenesis | 1.344051e-2 |
GO:0042335 | cuticle development | 1.344051e-2 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 1.344051e-2 |
GO:0060061 | Spemann organizer formation | 1.345389e-2 |
GO:0006498 | N-terminal protein lipidation | 1.345389e-2 |
GO:0035461 | vitamin transmembrane transport | 1.345389e-2 |
GO:0007126 | meiosis | 1.352425e-2 |
GO:0046031 | ADP metabolic process | 1.352943e-2 |
GO:0046607 | positive regulation of centrosome cycle | 1.365274e-2 |
GO:0061302 | smooth muscle cell-matrix adhesion | 1.365274e-2 |
GO:0006400 | tRNA modification | 1.379750e-2 |
GO:0051180 | vitamin transport | 1.384849e-2 |
GO:0070646 | protein modification by small protein removal | 1.385099e-2 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.386364e-2 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 1.388963e-2 |
GO:0019058 | viral infectious cycle | 1.422501e-2 |
GO:0006544 | glycine metabolic process | 1.428622e-2 |
GO:0060347 | heart trabecula formation | 1.463334e-2 |
GO:0019255 | glucose 1-phosphate metabolic process | 1.482877e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0030488 | tRNA methylation | 5.335076e-38 |
GO:0006400 | tRNA modification | 6.436164e-32 |
GO:0044260 | cellular macromolecule metabolic process | 2.881682e-22 |
GO:0009451 | RNA modification | 1.107619e-20 |
GO:0090304 | nucleic acid metabolic process | 2.141382e-19 |
GO:0034470 | ncRNA processing | 1.319521e-18 |
GO:0001510 | RNA methylation | 1.421310e-18 |
GO:0034660 | ncRNA metabolic process | 2.128068e-17 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.247983e-16 |
GO:0006396 | RNA processing | 1.659437e-16 |
GO:0010467 | gene expression | 6.577564e-16 |
GO:0008033 | tRNA processing | 6.591333e-16 |
GO:0006399 | tRNA metabolic process | 1.092906e-15 |
GO:0006412 | translation | 1.549236e-15 |
GO:0034382 | chylomicron remnant clearance | 2.876281e-15 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 7.416233e-15 |
GO:0010984 | regulation of lipoprotein particle clearance | 8.574394e-15 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 9.531096e-14 |
GO:0016070 | RNA metabolic process | 3.919090e-13 |
GO:0050995 | negative regulation of lipid catabolic process | 1.648468e-12 |
GO:0006974 | response to DNA damage stimulus | 2.214651e-12 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 2.294953e-12 |
GO:0010897 | negative regulation of triglyceride catabolic process | 2.294953e-12 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 3.428691e-12 |
GO:0042254 | ribosome biogenesis | 6.205955e-12 |
GO:0043170 | macromolecule metabolic process | 2.638471e-11 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 3.919508e-11 |
GO:0006139 | nucleobase-containing compound metabolic process | 4.810559e-11 |
GO:0060620 | regulation of cholesterol import | 9.912558e-11 |
GO:0060192 | negative regulation of lipase activity | 2.013553e-10 |
GO:0071843 | cellular component biogenesis at cellular level | 2.795060e-10 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 6.845464e-10 |
GO:0060621 | negative regulation of cholesterol import | 7.024086e-10 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.047967e-9 |
GO:2000772 | regulation of cellular senescence | 1.190595e-9 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.698164e-9 |
GO:0032375 | negative regulation of cholesterol transport | 4.186409e-9 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 4.326046e-9 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.889690e-9 |
GO:0006259 | DNA metabolic process | 5.534580e-9 |
GO:0050711 | negative regulation of interleukin-1 secretion | 6.129539e-9 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.350830e-8 |
GO:0071044 | histone mRNA catabolic process | 2.564702e-8 |
GO:0090234 | regulation of kinetochore assembly | 3.513402e-8 |
GO:0090169 | regulation of spindle assembly | 3.513402e-8 |
GO:0045806 | negative regulation of endocytosis | 3.845091e-8 |
GO:0043632 | modification-dependent macromolecule catabolic process | 3.934632e-8 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 4.703889e-8 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 4.735794e-8 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 5.273944e-8 |
GO:0008654 | phospholipid biosynthetic process | 6.067479e-8 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.680912e-8 |
GO:0034645 | cellular macromolecule biosynthetic process | 8.006493e-8 |
GO:0019941 | modification-dependent protein catabolic process | 8.365335e-8 |
GO:0042274 | ribosomal small subunit biogenesis | 8.860404e-8 |
GO:0016559 | peroxisome fission | 9.437546e-8 |
GO:0006346 | methylation-dependent chromatin silencing | 1.524456e-7 |
GO:0006413 | translational initiation | 2.508189e-7 |
GO:0009059 | macromolecule biosynthetic process | 2.797008e-7 |
GO:0090398 | cellular senescence | 2.861976e-7 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 3.505645e-7 |
GO:0006364 | rRNA processing | 4.678471e-7 |
GO:0031507 | heterochromatin formation | 4.721117e-7 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 5.084624e-7 |
GO:0034380 | high-density lipoprotein particle assembly | 5.313331e-7 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 5.555643e-7 |
GO:0016072 | rRNA metabolic process | 6.282201e-7 |
GO:0008334 | histone mRNA metabolic process | 6.552914e-7 |
GO:0044265 | cellular macromolecule catabolic process | 7.499654e-7 |
GO:0006807 | nitrogen compound metabolic process | 8.113450e-7 |
GO:0046599 | regulation of centriole replication | 8.164620e-7 |
GO:0006281 | DNA repair | 1.013343e-6 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 1.093410e-6 |
GO:0003341 | cilium movement | 1.424389e-6 |
GO:0051973 | positive regulation of telomerase activity | 1.713581e-6 |
GO:2000381 | negative regulation of mesoderm development | 1.713581e-6 |
GO:0044237 | cellular metabolic process | 1.794308e-6 |
GO:0000075 | cell cycle checkpoint | 1.889548e-6 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 1.963370e-6 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 2.017743e-6 |
GO:0010172 | embryonic body morphogenesis | 2.098064e-6 |
GO:0016071 | mRNA metabolic process | 2.153589e-6 |
GO:0060696 | regulation of phospholipid catabolic process | 2.170663e-6 |
GO:0032481 | positive regulation of type I interferon production | 3.535839e-6 |
GO:0051645 | Golgi localization | 3.565170e-6 |
GO:0035461 | vitamin transmembrane transport | 3.727805e-6 |
GO:2000774 | positive regulation of cellular senescence | 3.876759e-6 |
GO:0090402 | oncogene-induced senescence | 3.876759e-6 |
GO:0035986 | senescence-associated heterochromatin focus formation | 3.876759e-6 |
GO:0046474 | glycerophospholipid biosynthetic process | 4.553538e-6 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 4.679033e-6 |
GO:0034377 | plasma lipoprotein particle assembly | 4.829634e-6 |
GO:0034447 | very-low-density lipoprotein particle clearance | 4.882889e-6 |
GO:0008380 | RNA splicing | 5.855260e-6 |
GO:0031577 | spindle checkpoint | 6.314339e-6 |
GO:0010498 | proteasomal protein catabolic process | 6.571645e-6 |
GO:0090224 | regulation of spindle organization | 6.713879e-6 |
GO:0031572 | G2/M transition DNA damage checkpoint | 8.274111e-6 |
GO:0033239 | negative regulation of cellular amine metabolic process | 9.072932e-6 |
GO:0044257 | cellular protein catabolic process | 9.292191e-6 |
GO:0019047 | provirus integration | 9.419793e-6 |
GO:0034375 | high-density lipoprotein particle remodeling | 1.036445e-5 |
GO:0071103 | DNA conformation change | 1.157416e-5 |
GO:0030163 | protein catabolic process | 1.267997e-5 |
GO:0072560 | type B pancreatic cell maturation | 1.321236e-5 |
GO:0032488 | Cdc42 protein signal transduction | 1.327363e-5 |
GO:0010824 | regulation of centrosome duplication | 1.327363e-5 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.381516e-5 |
GO:0045919 | positive regulation of cytolysis | 1.414497e-5 |
GO:0034381 | plasma lipoprotein particle clearance | 1.868392e-5 |
GO:0033700 | phospholipid efflux | 1.908295e-5 |
GO:0090231 | regulation of spindle checkpoint | 1.984171e-5 |
GO:0071173 | spindle assembly checkpoint | 1.984171e-5 |
GO:0090342 | regulation of cell aging | 2.012003e-5 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 2.157439e-5 |
GO:0001522 | pseudouridine synthesis | 2.157439e-5 |
GO:0007141 | male meiosis I | 2.310199e-5 |
GO:0009057 | macromolecule catabolic process | 2.401194e-5 |
GO:0016926 | protein desumoylation | 2.456946e-5 |
GO:0002098 | tRNA wobble uridine modification | 2.456946e-5 |
GO:0046755 | non-lytic virus budding | 2.792392e-5 |
GO:0060285 | ciliary cell motility | 2.962104e-5 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 2.962104e-5 |
GO:0090209 | negative regulation of triglyceride metabolic process | 3.043194e-5 |
GO:0090343 | positive regulation of cell aging | 3.318536e-5 |
GO:0021884 | forebrain neuron development | 3.400799e-5 |
GO:0035520 | monoubiquitinated protein deubiquitination | 3.543812e-5 |
GO:2000078 | positive regulation of type B pancreatic cell development | 3.676848e-5 |
GO:0001555 | oocyte growth | 3.676848e-5 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 3.676848e-5 |
GO:0042273 | ribosomal large subunit biogenesis | 4.497861e-5 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 4.564226e-5 |
GO:0032425 | positive regulation of mismatch repair | 5.205268e-5 |
GO:0030038 | contractile actin filament bundle assembly | 5.420671e-5 |
GO:0035912 | dorsal aorta morphogenesis | 5.420671e-5 |
GO:0031576 | G2/M transition checkpoint | 5.436452e-5 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 5.585012e-5 |
GO:0045017 | glycerolipid biosynthetic process | 5.783443e-5 |
GO:0010735 | positive regulation of transcription via serum response element binding | 5.881439e-5 |
GO:0014020 | primary neural tube formation | 5.902744e-5 |
GO:0021658 | rhombomere 3 morphogenesis | 6.302965e-5 |
GO:0021794 | thalamus development | 6.440723e-5 |
GO:0014816 | satellite cell differentiation | 6.929455e-5 |
GO:0042384 | cilium assembly | 7.178297e-5 |
GO:0034446 | substrate adhesion-dependent cell spreading | 7.287881e-5 |
GO:0006260 | DNA replication | 7.645723e-5 |
GO:2000380 | regulation of mesoderm development | 7.685395e-5 |
GO:0060384 | innervation | 7.685395e-5 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 7.906915e-5 |
GO:0014029 | neural crest formation | 8.672074e-5 |
GO:0001843 | neural tube closure | 9.444517e-5 |
GO:0034369 | plasma lipoprotein particle remodeling | 9.488371e-5 |
GO:0032369 | negative regulation of lipid transport | 9.917400e-5 |
GO:0016567 | protein ubiquitination | 9.918698e-5 |
GO:0007049 | cell cycle | 1.010549e-4 |
GO:0070508 | cholesterol import | 1.047097e-4 |
GO:0032479 | regulation of type I interferon production | 1.091161e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 1.110680e-4 |
GO:0034227 | tRNA thio-modification | 1.127658e-4 |
GO:0071156 | regulation of cell cycle arrest | 1.181404e-4 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 1.228012e-4 |
GO:0006397 | mRNA processing | 1.286307e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 1.299775e-4 |
GO:0006683 | galactosylceramide catabolic process | 1.299775e-4 |
GO:0031129 | inductive cell-cell signaling | 1.510416e-4 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.542064e-4 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 1.546141e-4 |
GO:0060606 | tube closure | 1.618643e-4 |
GO:0021539 | subthalamus development | 1.681332e-4 |
GO:0006686 | sphingomyelin biosynthetic process | 1.681519e-4 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 1.715371e-4 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 1.715371e-4 |
GO:0010564 | regulation of cell cycle process | 1.778424e-4 |
GO:0021506 | anterior neuropore closure | 1.782126e-4 |
GO:0030433 | ER-associated protein catabolic process | 1.884277e-4 |
GO:0060218 | hemopoietic stem cell differentiation | 1.975373e-4 |
GO:0070647 | protein modification by small protein conjugation or removal | 2.060197e-4 |
GO:0033554 | cellular response to stress | 2.094113e-4 |
GO:0046605 | regulation of centrosome cycle | 2.113479e-4 |
GO:0046513 | ceramide biosynthetic process | 2.138304e-4 |
GO:0035887 | aortic smooth muscle cell differentiation | 2.274663e-4 |
GO:0044267 | cellular protein metabolic process | 2.307829e-4 |
GO:0015887 | pantothenate transmembrane transport | 2.419204e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 2.419204e-4 |
GO:0015878 | biotin transport | 2.419204e-4 |
GO:0010948 | negative regulation of cell cycle process | 2.463818e-4 |
GO:0021559 | trigeminal nerve development | 2.659921e-4 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 2.664174e-4 |
GO:0032203 | telomere formation via telomerase | 2.741593e-4 |
GO:0070723 | response to cholesterol | 2.857380e-4 |
GO:0006323 | DNA packaging | 2.903037e-4 |
GO:0035284 | brain segmentation | 2.974075e-4 |
GO:0007076 | mitotic chromosome condensation | 2.982033e-4 |
GO:0071281 | cellular response to iron ion | 3.104532e-4 |
GO:0032508 | DNA duplex unwinding | 3.179261e-4 |
GO:0048935 | peripheral nervous system neuron development | 3.437138e-4 |
GO:0032202 | telomere assembly | 3.619454e-4 |
GO:0006407 | rRNA export from nucleus | 3.619454e-4 |
GO:0000089 | mitotic metaphase | 3.619454e-4 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 3.645725e-4 |
GO:0032446 | protein modification by small protein conjugation | 4.130993e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 4.244561e-4 |
GO:0006235 | dTTP biosynthetic process | 4.244561e-4 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 4.294586e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 4.294586e-4 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 4.294586e-4 |
GO:0071392 | cellular response to estradiol stimulus | 4.459294e-4 |
GO:0032392 | DNA geometric change | 4.459294e-4 |
GO:0071827 | plasma lipoprotein particle organization | 4.676002e-4 |
GO:0006308 | DNA catabolic process | 4.916810e-4 |
GO:0009895 | negative regulation of catabolic process | 5.000847e-4 |
GO:0006921 | cellular component disassembly involved in apoptosis | 5.060314e-4 |
GO:0042255 | ribosome assembly | 5.111626e-4 |
GO:0071872 | cellular response to epinephrine stimulus | 5.244121e-4 |
GO:0042268 | regulation of cytolysis | 5.625977e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 5.625977e-4 |
GO:0021695 | cerebellar cortex development | 5.656476e-4 |
GO:0045739 | positive regulation of DNA repair | 5.821587e-4 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 5.880560e-4 |
GO:0015739 | sialic acid transport | 5.880560e-4 |
GO:0006844 | acyl carnitine transport | 5.880560e-4 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 5.880560e-4 |
GO:0051684 | maintenance of Golgi location | 5.943842e-4 |
GO:0048291 | isotype switching to IgG isotypes | 5.943842e-4 |
GO:0002368 | B cell cytokine production | 5.943842e-4 |
GO:0070170 | regulation of tooth mineralization | 6.286279e-4 |
GO:0006089 | lactate metabolic process | 6.286279e-4 |
GO:0030262 | apoptotic nuclear change | 6.430881e-4 |
GO:0021508 | floor plate formation | 6.489203e-4 |
GO:0042157 | lipoprotein metabolic process | 6.517154e-4 |
GO:0000209 | protein polyubiquitination | 6.597702e-4 |
GO:0006506 | GPI anchor biosynthetic process | 6.616735e-4 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 6.641996e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 6.914801e-4 |
GO:0006656 | phosphatidylcholine biosynthetic process | 7.019089e-4 |
GO:0006684 | sphingomyelin metabolic process | 7.044186e-4 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 7.237486e-4 |
GO:0046520 | sphingoid biosynthetic process | 7.463927e-4 |
GO:0051403 | stress-activated MAPK cascade | 7.599801e-4 |
GO:0010656 | negative regulation of muscle cell apoptosis | 7.606699e-4 |
GO:0021683 | cerebellar granular layer morphogenesis | 7.671451e-4 |
GO:0006713 | glucocorticoid catabolic process | 7.720864e-4 |
GO:0032374 | regulation of cholesterol transport | 8.130486e-4 |
GO:0033344 | cholesterol efflux | 8.145897e-4 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 8.737181e-4 |
GO:0006013 | mannose metabolic process | 8.754948e-4 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 8.961851e-4 |
GO:0006473 | protein acetylation | 8.997498e-4 |
GO:0001839 | neural plate morphogenesis | 9.135792e-4 |
GO:0006282 | regulation of DNA repair | 9.389075e-4 |
GO:0007569 | cell aging | 9.442905e-4 |
GO:0071394 | cellular response to testosterone stimulus | 9.505163e-4 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 9.505163e-4 |
GO:0021623 | oculomotor nerve formation | 1.022302e-3 |
GO:0003404 | optic vesicle morphogenesis | 1.022302e-3 |
GO:0003409 | optic cup structural organization | 1.022302e-3 |
GO:2000384 | negative regulation of ectoderm development | 1.028066e-3 |
GO:0065005 | protein-lipid complex assembly | 1.038464e-3 |
GO:0032423 | regulation of mismatch repair | 1.049941e-3 |
GO:0045833 | negative regulation of lipid metabolic process | 1.126909e-3 |
GO:0048285 | organelle fission | 1.149333e-3 |
GO:0071985 | multivesicular body sorting pathway | 1.162651e-3 |
GO:0048259 | regulation of receptor-mediated endocytosis | 1.176630e-3 |
GO:0051661 | maintenance of centrosome location | 1.206427e-3 |
GO:0035611 | protein branching point deglutamylation | 1.206427e-3 |
GO:0070370 | cellular heat acclimation | 1.217441e-3 |
GO:0060699 | regulation of endoribonuclease activity | 1.217441e-3 |
GO:0000055 | ribosomal large subunit export from nucleus | 1.217441e-3 |
GO:0000056 | ribosomal small subunit export from nucleus | 1.217441e-3 |
GO:0021603 | cranial nerve formation | 1.219588e-3 |
GO:0001672 | regulation of chromatin assembly or disassembly | 1.243223e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 1.295748e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.304410e-3 |
GO:0051972 | regulation of telomerase activity | 1.304859e-3 |
GO:0043248 | proteasome assembly | 1.304859e-3 |
GO:0007031 | peroxisome organization | 1.309734e-3 |
GO:0085020 | protein K6-linked ubiquitination | 1.345870e-3 |
GO:0070537 | histone H2A K63-linked deubiquitination | 1.345870e-3 |
GO:0051182 | coenzyme transport | 1.345870e-3 |
GO:0051865 | protein autoubiquitination | 1.402938e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1.421525e-3 |
GO:0051726 | regulation of cell cycle | 1.460324e-3 |
GO:0035115 | embryonic forelimb morphogenesis | 1.527565e-3 |
GO:0006475 | internal protein amino acid acetylation | 1.549703e-3 |
GO:0043497 | regulation of protein heterodimerization activity | 1.561718e-3 |
GO:0035372 | protein localization to microtubule | 1.582596e-3 |
GO:0014034 | neural crest cell fate commitment | 1.582596e-3 |
GO:0043252 | sodium-independent organic anion transport | 1.631456e-3 |
GO:0000027 | ribosomal large subunit assembly | 1.631456e-3 |
GO:0002561 | basophil degranulation | 1.631456e-3 |
GO:0071034 | CUT catabolic process | 1.727973e-3 |
GO:0032774 | RNA biosynthetic process | 1.746200e-3 |
GO:0034063 | stress granule assembly | 1.760195e-3 |
GO:0043543 | protein acylation | 1.781376e-3 |
GO:0046479 | glycosphingolipid catabolic process | 1.830809e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.865405e-3 |
GO:0050994 | regulation of lipid catabolic process | 1.914240e-3 |
GO:0046519 | sphingoid metabolic process | 1.954889e-3 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 1.994018e-3 |
GO:0006351 | transcription, DNA-dependent | 2.023188e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 2.077099e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 2.077099e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 2.107309e-3 |
GO:0030149 | sphingolipid catabolic process | 2.137392e-3 |
GO:0000460 | maturation of 5.8S rRNA | 2.139389e-3 |
GO:0051775 | response to redox state | 2.200674e-3 |
GO:0002679 | respiratory burst involved in defense response | 2.255040e-3 |
GO:0031122 | cytoplasmic microtubule organization | 2.391395e-3 |
GO:2000383 | regulation of ectoderm development | 2.451130e-3 |
GO:0000087 | M phase of mitotic cell cycle | 2.463940e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 2.471847e-3 |
GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport | 2.485439e-3 |
GO:0061034 | olfactory bulb mitral cell layer development | 2.488259e-3 |
GO:0006513 | protein monoubiquitination | 2.527411e-3 |
GO:0033505 | floor plate morphogenesis | 2.563871e-3 |
GO:0021707 | cerebellar granule cell differentiation | 2.597749e-3 |
GO:0006268 | DNA unwinding involved in replication | 2.597749e-3 |
GO:0008211 | glucocorticoid metabolic process | 2.599533e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 2.656661e-3 |
GO:0045648 | positive regulation of erythrocyte differentiation | 2.771153e-3 |
GO:0070172 | positive regulation of tooth mineralization | 2.841959e-3 |
GO:0021549 | cerebellum development | 2.852628e-3 |
GO:0006342 | chromatin silencing | 2.873017e-3 |
GO:0006672 | ceramide metabolic process | 2.888359e-3 |
GO:0021681 | cerebellar granular layer development | 2.980605e-3 |
GO:0044238 | primary metabolic process | 3.057020e-3 |
GO:0035092 | sperm chromatin condensation | 3.076914e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 3.119032e-3 |
GO:0034421 | post-translational protein acetylation | 3.150753e-3 |
GO:0003151 | outflow tract morphogenesis | 3.177140e-3 |
GO:0006261 | DNA-dependent DNA replication | 3.354717e-3 |
GO:0044249 | cellular biosynthetic process | 3.375993e-3 |
GO:0033561 | regulation of water loss via skin | 3.421174e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.443592e-3 |
GO:0002536 | respiratory burst involved in inflammatory response | 3.474334e-3 |
GO:0042697 | menopause | 3.474334e-3 |
GO:0071028 | nuclear mRNA surveillance | 3.484169e-3 |
GO:0045575 | basophil activation | 3.484169e-3 |
GO:0035750 | protein localization to myelin sheath abaxonal region | 3.484169e-3 |
GO:0021846 | cell proliferation in forebrain | 3.514750e-3 |
GO:2000036 | regulation of stem cell maintenance | 3.583947e-3 |
GO:0071934 | thiamine transmembrane transport | 3.680856e-3 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 3.680856e-3 |
GO:0035621 | ER to Golgi ceramide transport | 3.680856e-3 |
GO:0031570 | DNA integrity checkpoint | 3.741844e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 3.772364e-3 |
GO:0000281 | cytokinesis after mitosis | 3.772364e-3 |
GO:0060932 | His-Purkinje system cell differentiation | 3.812833e-3 |
GO:0060926 | pacemaker cell development | 3.812833e-3 |
GO:0021569 | rhombomere 3 development | 3.843039e-3 |
GO:0001732 | formation of translation initiation complex | 4.053755e-3 |
GO:0032055 | negative regulation of translation in response to stress | 4.053755e-3 |
GO:0070936 | protein K48-linked ubiquitination | 4.115751e-3 |
GO:0031497 | chromatin assembly | 4.118247e-3 |
GO:0000077 | DNA damage checkpoint | 4.127542e-3 |
GO:0007059 | chromosome segregation | 4.135515e-3 |
GO:0060911 | cardiac cell fate commitment | 4.206993e-3 |
GO:0045666 | positive regulation of neuron differentiation | 4.409066e-3 |
GO:0048668 | collateral sprouting | 4.422845e-3 |
GO:0016075 | rRNA catabolic process | 4.422845e-3 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.422845e-3 |
GO:0042481 | regulation of odontogenesis | 4.479594e-3 |
GO:0016482 | cytoplasmic transport | 4.479832e-3 |
GO:0030505 | inorganic diphosphate transport | 4.484778e-3 |
GO:0000028 | ribosomal small subunit assembly | 4.513213e-3 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 4.589318e-3 |
GO:0043488 | regulation of mRNA stability | 4.612130e-3 |
GO:0070979 | protein K11-linked ubiquitination | 4.644814e-3 |
GO:0045646 | regulation of erythrocyte differentiation | 4.650282e-3 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 4.736243e-3 |
GO:0021758 | putamen development | 4.736243e-3 |
GO:0071474 | cellular hyperosmotic response | 4.736243e-3 |
GO:0021660 | rhombomere 3 formation | 4.736243e-3 |
GO:0021666 | rhombomere 5 formation | 4.736243e-3 |
GO:0021757 | caudate nucleus development | 4.736243e-3 |
GO:0033261 | regulation of S phase | 4.844612e-3 |
GO:0006505 | GPI anchor metabolic process | 5.178865e-3 |
GO:0023021 | termination of signal transduction | 5.437219e-3 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 5.437219e-3 |
GO:0007067 | mitosis | 5.547899e-3 |
GO:0022037 | metencephalon development | 5.686928e-3 |
GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure | 5.758548e-3 |
GO:0010825 | positive regulation of centrosome duplication | 5.758548e-3 |
GO:0000917 | barrier septum formation | 5.758548e-3 |
GO:0034661 | ncRNA catabolic process | 5.911129e-3 |
GO:0042733 | embryonic digit morphogenesis | 5.936481e-3 |
GO:0007220 | Notch receptor processing | 6.193802e-3 |
GO:0046600 | negative regulation of centriole replication | 6.314332e-3 |
GO:0034441 | plasma lipoprotein particle oxidation | 6.314332e-3 |
GO:0001881 | receptor recycling | 6.314332e-3 |
GO:0009992 | cellular water homeostasis | 6.314332e-3 |
GO:2000050 | regulation of non-canonical Wnt receptor signaling pathway | 6.371832e-3 |
GO:0007635 | chemosensory behavior | 6.371832e-3 |
GO:0006258 | UDP-glucose catabolic process | 6.380282e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 6.380282e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 6.380282e-3 |
GO:0010835 | regulation of protein ADP-ribosylation | 6.380282e-3 |
GO:0046514 | ceramide catabolic process | 6.400802e-3 |
GO:0006481 | C-terminal protein methylation | 6.458409e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 6.458409e-3 |
GO:0046477 | glycosylceramide catabolic process | 6.624530e-3 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 6.658141e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 6.813345e-3 |
GO:0050709 | negative regulation of protein secretion | 6.880784e-3 |
GO:0006661 | phosphatidylinositol biosynthetic process | 7.056720e-3 |
GO:0051181 | cofactor transport | 7.362586e-3 |
GO:0071870 | cellular response to catecholamine stimulus | 7.653614e-3 |
GO:0060931 | sinoatrial node cell development | 7.893842e-3 |
GO:0032876 | negative regulation of DNA endoreduplication | 7.893842e-3 |
GO:0003167 | atrioventricular bundle cell differentiation | 7.893842e-3 |
GO:0032776 | DNA methylation on cytosine | 7.893842e-3 |
GO:0043687 | post-translational protein modification | 7.908736e-3 |
GO:0035136 | forelimb morphogenesis | 7.951235e-3 |
GO:0030168 | platelet activation | 7.967985e-3 |
GO:0021675 | nerve development | 8.059660e-3 |
GO:0090074 | negative regulation of protein homodimerization activity | 8.252580e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 8.252580e-3 |
GO:0001954 | positive regulation of cell-matrix adhesion | 8.378406e-3 |
GO:0043487 | regulation of RNA stability | 8.503212e-3 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 8.520461e-3 |
GO:0006695 | cholesterol biosynthetic process | 8.625253e-3 |
GO:0043206 | fibril organization | 8.667150e-3 |
GO:0048532 | anatomical structure arrangement | 8.777364e-3 |
GO:0033490 | cholesterol biosynthetic process via lathosterol | 8.823627e-3 |
GO:0006011 | UDP-glucose metabolic process | 8.823627e-3 |
GO:0022601 | menstrual cycle phase | 8.898723e-3 |
GO:0010159 | specification of organ position | 9.020073e-3 |
GO:0001840 | neural plate development | 9.039015e-3 |
GO:0000278 | mitotic cell cycle | 9.121553e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 9.133192e-3 |
GO:0007418 | ventral midline development | 9.219921e-3 |
GO:0030953 | astral microtubule organization | 9.331990e-3 |
GO:0010660 | regulation of muscle cell apoptosis | 9.355293e-3 |
GO:0006302 | double-strand break repair | 9.503108e-3 |
GO:0032859 | activation of Ral GTPase activity | 9.592440e-3 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 9.601608e-3 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 9.712103e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 9.712103e-3 |
GO:0060920 | pacemaker cell differentiation | 9.712103e-3 |
GO:0051301 | cell division | 9.937833e-3 |
GO:0046434 | organophosphate catabolic process | 1.007673e-2 |
GO:0046466 | membrane lipid catabolic process | 1.007755e-2 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.030800e-2 |
GO:0048550 | negative regulation of pinocytosis | 1.030800e-2 |
GO:0090182 | regulation of secretion of lysosomal enzymes | 1.030800e-2 |
GO:0090186 | regulation of pancreatic juice secretion | 1.030800e-2 |
GO:0071048 | nuclear retention of unspliced pre-mRNA at the site of transcription | 1.030800e-2 |
GO:0071035 | nuclear polyadenylation-dependent rRNA catabolic process | 1.030800e-2 |
GO:0048239 | negative regulation of DNA recombination at telomere | 1.030800e-2 |
GO:0001971 | negative regulation of activation of membrane attack complex | 1.030800e-2 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.030800e-2 |
GO:0003327 | type B pancreatic cell fate commitment | 1.030800e-2 |
GO:0018125 | peptidyl-cysteine methylation | 1.030800e-2 |
GO:0031629 | synaptic vesicle fusion to presynaptic membrane | 1.030800e-2 |
GO:0071025 | RNA surveillance | 1.051937e-2 |
GO:0001787 | natural killer cell proliferation | 1.051937e-2 |
GO:0015876 | acetyl-CoA transport | 1.051937e-2 |
GO:0034101 | erythrocyte homeostasis | 1.053093e-2 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 1.059499e-2 |
GO:0070842 | aggresome assembly | 1.059499e-2 |
GO:0010225 | response to UV-C | 1.099427e-2 |
GO:2001020 | regulation of response to DNA damage stimulus | 1.104835e-2 |
GO:0030031 | cell projection assembly | 1.110028e-2 |
GO:0034763 | negative regulation of transmembrane transport | 1.113088e-2 |
GO:0003166 | bundle of His development | 1.117443e-2 |
GO:0090187 | positive regulation of pancreatic juice secretion | 1.140241e-2 |
GO:0090340 | positive regulation of secretion of lysosomal enzymes | 1.140241e-2 |
GO:0090108 | positive regulation of high-density lipoprotein particle assembly | 1.140241e-2 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 1.140241e-2 |
GO:0007113 | endomitotic cell cycle | 1.140241e-2 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.141856e-2 |
GO:0000279 | M phase | 1.151438e-2 |
GO:0061384 | heart trabecular morphogenesis | 1.158369e-2 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 1.161431e-2 |
GO:0045039 | protein import into mitochondrial inner membrane | 1.161431e-2 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.169859e-2 |
GO:0072537 | fibroblast activation | 1.174894e-2 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 1.174894e-2 |
GO:0002432 | granuloma formation | 1.174894e-2 |
GO:0010046 | response to mycotoxin | 1.174894e-2 |
GO:0006424 | glutamyl-tRNA aminoacylation | 1.174894e-2 |
GO:0006422 | aspartyl-tRNA aminoacylation | 1.174894e-2 |
GO:0031330 | negative regulation of cellular catabolic process | 1.182354e-2 |
GO:2000104 | negative regulation of DNA-dependent DNA replication | 1.201068e-2 |
GO:0006354 | transcription elongation, DNA-dependent | 1.212345e-2 |
GO:0032692 | negative regulation of interleukin-1 production | 1.213094e-2 |
GO:0060806 | negative regulation of cell differentiation involved in embryonic placenta development | 1.213421e-2 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.213421e-2 |
GO:0031061 | negative regulation of histone methylation | 1.227483e-2 |
GO:0071826 | ribonucleoprotein complex subunit organization | 1.262854e-2 |
GO:0021557 | oculomotor nerve development | 1.277806e-2 |
GO:0007525 | somatic muscle development | 1.277806e-2 |
GO:0071470 | cellular response to osmotic stress | 1.280511e-2 |
GO:0031573 | intra-S DNA damage checkpoint | 1.280511e-2 |
GO:0021696 | cerebellar cortex morphogenesis | 1.293462e-2 |
GO:0070536 | protein K63-linked deubiquitination | 1.311341e-2 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.331064e-2 |
GO:0008215 | spermine metabolic process | 1.338481e-2 |
GO:0060347 | heart trabecula formation | 1.350826e-2 |
GO:0032728 | positive regulation of interferon-beta production | 1.383752e-2 |